Banking on hope, swayed by hype? Hydroxychloroquine in the time of Covid-19

Banking on hope, swayed by hype? Hydroxychloroquine in the time of Covid-19
As coronavirus deaths amassed and already stretched health care systems in Europe, and the United States groaned with the added weight of the pandemic, the FDA and EMA agencies adopted contradictory tones over the use of a pair of decades-old malaria drugs to fight the virus — epitomizing the desperation to combat an uncharted disease.

“This is just another example that points to the fact that while EMA and FDA oftentimes take the same position, they also take contrary positions,” said Peter Pitts, who served as the FDA’s associate commissioner for external relations between 2002 and 2004. “We are addressing Covid-19 in a variety of ways, and so is the EMA — the circles are concentric, but they are not identical.”
Sign Up for Our Email Newsletter

RECENT NEWS

Truth vs. Tort
  • CMPI
  • 07/18/2024 12:00 AM

Truth vs. Tort

New litigation alleging preterm infant formula and human milk fortifiers cause NEC distorts the facts and ignores what th...  Read more

New CMPI Book: And Nothing But the Truth

New CMPI Book: And Nothing But the Truth

Healthcare evolution, in technology and policy, is a never-ending parade of complicated and contradictory truths. This bo...  Read more

Tort bar’s newest collateral damage: Preterm babies

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers...  Read more

DRUGWONKS BLOG